Future Market Insights (FMI) projects stellar growth for the
global nutraceutical
excipients market ,forecasting it to reach a valuation of US$
2186.2 Mn by 2021. Demand for nutraceutical excipients is expected to
remain positive, increasing at a CAGR of 7.10% between 2021
and 2031. Rising prevalence of lifestyle disorders among geriatric population
and increasing adoption of dry nutraceutical excipients among manufacturers
have augmented the market growth.
Increasing use in pre & probiotics, omega 3 fatty acids,
and ease in regulatory approval by international organizations such as the U.S.
Food & Drug Administration are the key factors driving growth in the
market.
The rising demand for dietary supplements and
increasing cases of cardiovascular diseases across the U.S., Germany, Japan and
the UK have boosted the adoption of dietary and nutritional food supplements.
Increasing demand for multi-functional excipients and
adoption of oral solid drug formulation among key player for the manufacturing
of dry nutraceutical excipients such as tablets, powder forms will continue,
creating opportunities for growth.
Spurred by these factors, FMI projects nutraceutical
excipients sales to surge at 7.10% CAGR during 2021 and
2031.
Key Takeaways from FMI’s Nutraceutical Excipients Market
Study
- In
terms of product type, binders and fillers & diluents will remain the
most sought after type of nutraceutical excipients
- Dry
nutraceutical excipients will account for over 3/5th of
the global market demand over the forecast period
- The
U.S. will emerge as the most lucrative market backed by the rising prevalence
of lifestyle disease among geriatric population
- France
and the U.K., collectively, will emerge as the most lucrative market
across Europe in the upcoming decade
- Japan
is anticipated to emerge as a lucrative market backed by the high
prevalence of cardiovascular disease and osteoarthritis among geriatric
population
- India
is anticipated to register high demand over the forecast period owing to
the rising government initiatives and high intake of dietary supplements
“Increasing research & development activities
and fast-track regulatory framework have been creating opportunities for growth
in the market. Overall, the focus on producing high quality nutraceutical
excipients will remain top priority for the market players,” says the FMI
analyst.
Competitive Landscape
Leading manufacturers of nutraceutical excipients are
focusing on product development to gain competitive edge. They also are
investing heavily in research & development activities to develop
multi-functional excipients with advanced properties to improve the product
efficiency. Besides this, they are adopting a slew of expansion strategies to
strengthen their footprint worldwide.
For instance, on November 2020, IMCD, a leading global
distributor of specialty chemicals and ingredients announced the acquisition
of Signet Excipients Private Limited. IMCD will announce the complete
acquisition of Signet by 2024 as currently it has acquired 70% of the company’s
share and will acquire 30% in 2024.
In 2019, Ropack Pharma Solutions announced the dry blending
services for API’s excipients as well as nutraceuticals catering to
pharmaceuticals standards.
More Insights on the Global Nutraceuticals Excipients
Market
Nutraceutical Excipients Market by Category
By Product Type:
- Binder
- MCC
- HPMC
- HPC
- Disintegrants
- Crosspovidone
- Croscarmellose
- Fillers
& Diluents
- Coating
Agent
- Flavoring
Agent
- Lubricants
- Others
By End Use:
- Protein
and Amino Acids
- Omega
3 Fatty Acids
- Vitamins
- Minerals
- Prebiotics
and Probiotics
- Others
By Form:
- Dry
- Liquid
By Region:
- North
America
- Latin
America
- Europe
- East
Asia
- South
Asia
- Oceania
- Middle
East & Africa
Thanks for reading this article; you can also get
individual chapter wise section or region wise report version like North
America, Europe or Asia.
Read More: https://www.futuremarketinsights.com/reports/nutraceutical-excipients-market